文献速递心血管USMRCTPET

影像学评估二尖瓣脱垂致心律失常潜能的综述

Imaging for the assessment of the arrhythmogenic potential of mitral valve prolapse.
PubMed 文献 · Eur Radiol · 2023-12-11

二尖瓣脱垂是西方世界最常见的瓣膜病,可能与复杂室性心律失常及心源性猝死相关,年风险约0.2%至1.9%。本综述概述影像学在二尖瓣脱垂心律失常风险分层中的作用,重点阐述超声心动图与心脏磁共振可识别的形态、运动及结构异常,中心脏磁共振检测的心肌纤维化目前是最强预后指标。

要点

  • 二尖瓣脱垂患者年心源性猝死风险约0.2%至1.9%,多由复杂室性心律失常所致。
  • 超声心动图可识别瓣叶冗余增厚、瓣环扩张、瓣环分离及「Pickelhaube」征等室性心律失常预后征象。
  • 心脏磁共振可综合评估形态、运动异常及心肌纤维化,后者目前是最强预后指标。

核心结论

  • 影像学在识别二尖瓣脱垂患者与复杂室性心律失常及心源性猝死高风险相关的解剖、功能、机械及结构改变中起核心作用。
  • 心脏磁共振能结合形态与运动改变识别及心肌纤维化检测进行综合风险分层,是二尖瓣脱垂患者心律失常风险分层的理想方法。
  • 近期研究提示混合PET-MR与晚期对比增强CT等新技术可能在风险分层中具有潜在作用。

研究设计与样本

  • 本综述旨在概述二尖瓣脱垂综合征,重点阐述影像学在心律失常风险分层中的作用。

关键影像表现/征象

  • 超声心动图可检测的形态学改变包括瓣叶冗余和增厚、二尖瓣环扩张及二尖瓣环分离。
  • 超声心动图可检测的运动异常包括「Pickelhaube」征。
  • 斑点追踪超声心动图可通过检测机械离散度增加来识别室性心律失常风险较高的二尖瓣脱垂患者。
  • 心脏磁共振可识别形态与运动改变,并检测心肌替代性纤维化及间质纤维化。
  • 混合PET-MR与晚期对比增强CT在风险分层中的潜在作用已获近期研究提示。

诊断标准与关键数值

  • 二尖瓣脱垂患者发生心源性猝死的年风险估计为0.2%至1.9%,多由复杂室性心律失常所致。
  • 斑点追踪超声心动图检测机械离散度增加可识别室性心律失常风险较高的二尖瓣脱垂患者。
  • 心脏磁共振检测的心肌纤维化目前是最强预后指标。

临床应用与阅片要点

  • 超声心动图在二尖瓣脱垂诊断及反流严重程度评估中起核心作用。
  • 超声心动图可评估瓣叶冗余和厚度、二尖瓣环扩张、二尖瓣环分离及「Pickelhaube」征等室性心律失常预后征象。
  • 斑点追踪超声心动图可通过机械离散度增加识别室性心律失常风险较高的二尖瓣脱垂患者。
  • 心脏磁共振可综合形态、运动改变与心肌纤维化检测进行心律失常风险分层。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Mitral valve prolapse (MVP) is the most common valve disease in the western world and recently emerged as a possible substrate for sudden cardiac death (SCD). It is estimated an annual risk of sudden cardiac death of 0.2 to 1.9% mostly caused by complex ventricular arrhythmias (VA). Several mechanisms have been recognized as potentially responsible for arrhythmia onset in MVP, resulting from the combination of morpho-functional abnormality of the mitral valve, structural substrates (regional myocardial hypertrophy, fibrosis, Purkinje fibers activity, inflammation), and mechanical stretch. Echocardiography plays a central role in MVP diagnosis and assessment of severity of regurgitation. Several abnormalities detectable by echocardiography can be prognostic for the occurrence of VA, from morphological alteration including leaflet redundancy and thickness, mitral annular dilatation, and mitral annulus disjunction (MAD), to motion abnormalities detectable with "Pickelhaube" sign. Additionally, speckle-tracking echocardiography may identify MVP patients at higher risk for VA by detection of increased mechanical dispersion. On the other hand, cardiac magnetic resonance (CMR) has the capability to provide a comprehensive risk stratification combining the identification of morphological and motion alteration with the detection of myocardial replacement and interstitial fibrosis, making CMR an ideal method for arrhythmia risk stratification in patients with MVP. Finally, recent studies have suggested a potential role in risk stratification of new techniques such as hybrid PET-MR and late contrast enhancement CT. The purpose of this review is to provide an overview of the mitral valve prolapse syndrome with a focus on the role of imaging in arrhythmic risk stratification. CLINICAL RELEVANCE STATEMENT: Mitral valve prolapse is the most frequent valve condition potentially associated with arrhythmias. Imaging has a central role in the identification of anatomical, functional, mechanical, and structural alterations potentially associated with a higher risk of developing complex ventricular arrhythmia and sudden cardiac death. KEY POINTS: • Mitral valve prolapse is a common valve disease potentially associated with complex ventricular arrhythmia and sudden cardiac death. • The mechanism of arrhythmogenesis in mitral valve prolapse is complex and multifactorial, due to the interplay among multiple conditions including valve morphological alteration, mechanical stretch, myocardial structure remodeling with fibrosis, and inflammation. • Cardiac imaging, especially echocardiography and cardiac magnetic resonance, is crucial in the identification of several features associated with the potential risk of serious cardiac events. In particular, cardiac magnetic resonance has the advantage of being able to detect myocardial fibrosis which is currently the strongest prognosticator.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Esposito A, Gatti M, Trivieri MG, et al. Imaging for the assessment of the arrhythmogenic potential of mitral valve prolapse. Eur Radiol. 2023. PMID: 38078997. doi:10.1007/s00330-023-10413-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。